These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 2824604

  • 21. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA, Pedersen KF, Welsh RM.
    J Immunol; 1986 Jul 15; 137(2):463-71. PubMed ID: 3722814
    [Abstract] [Full Text] [Related]

  • 22. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
    Lotzová E, Savary CA, Herberman RB.
    J Immunol; 1987 Apr 15; 138(8):2718-27. PubMed ID: 3494084
    [Abstract] [Full Text] [Related]

  • 23. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.
    Int J Oncol; 2004 May 15; 24(5):1165-74. PubMed ID: 15067338
    [Abstract] [Full Text] [Related]

  • 24. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
    Laso FJ, Madruga JI, Girón JA, López A, Ciudad J, San Miguel JF, Alvarez-Mon M, Orfao A.
    Hepatology; 1997 May 15; 25(5):1096-100. PubMed ID: 9141423
    [Abstract] [Full Text] [Related]

  • 25. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
    Seki H, Ueno Y, Taga K, Matsuda A, Miyawaki T, Taniguchi N.
    J Immunol; 1985 Oct 15; 135(4):2351-6. PubMed ID: 3928745
    [Abstract] [Full Text] [Related]

  • 26. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE, Hercend T, Fox DA, Bensussan A, Bartley G, Daley JF, Schlossman SF, Reinherz EL, Ritz J.
    J Immunol; 1985 Jul 15; 135(1):672-8. PubMed ID: 3923116
    [Abstract] [Full Text] [Related]

  • 27. Specific recognition of virus-infected cells by paired NK receptors.
    Arase H, Lanier LL.
    Rev Med Virol; 2004 Jul 15; 14(2):83-93. PubMed ID: 15027001
    [Abstract] [Full Text] [Related]

  • 28. Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing.
    Giardina SL, Anderson SK, Sayers TJ, Chambers WH, Palumbo GA, Young HA, Ortaldo JR.
    J Immunol; 1995 Jan 01; 154(1):80-7. PubMed ID: 7995961
    [Abstract] [Full Text] [Related]

  • 29. Decreased natural killer activity in thalassemia major: a possible consequence of iron overload.
    Akbar AN, Fitzgerald-Bocarsly PA, de Sousa M, Giardina PJ, Hilgartner MW, Grady RW.
    J Immunol; 1986 Mar 01; 136(5):1635-40. PubMed ID: 3005397
    [Abstract] [Full Text] [Related]

  • 30. A novel type of human T cell clone with highly potent natural killer-like cytotoxicity divorced from large granular lymphocyte morphology.
    Schneider EM, Pawelec GP, Liangru S, Wernet P.
    J Immunol; 1984 Jul 01; 133(1):173-9. PubMed ID: 6609974
    [Abstract] [Full Text] [Related]

  • 31. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC.
    Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412
    [Abstract] [Full Text] [Related]

  • 32. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
    van de Griend RJ, van Krimpen BA, Ronteltap CP, Bolhuis RL.
    J Immunol; 1984 Jun 15; 132(6):3185-91. PubMed ID: 6233369
    [Abstract] [Full Text] [Related]

  • 33. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
    Jezewska E, Björkholm M, Giscombe R, Holm G, Tullgren O.
    Clin Exp Immunol; 1985 Jul 15; 61(1):96-102. PubMed ID: 4042422
    [Abstract] [Full Text] [Related]

  • 34. Control of human herpes virus type 8-associated diseases by NK cells.
    Sirianni MC, Campagna M, Scaramuzzi D, Carbonari M, Toschi E, Bacigalupo I, Monini P, Ensoli B.
    Ann N Y Acad Sci; 2007 Jan 15; 1096():37-43. PubMed ID: 17405914
    [Abstract] [Full Text] [Related]

  • 35. Natural killing in immunodeficient patients.
    Koren HS, Amos DB, Buckley RH.
    J Immunol; 1978 Mar 15; 120(3):796-9. PubMed ID: 632589
    [Abstract] [Full Text] [Related]

  • 36. Heterogeneity of human natural killer cells in the spleen.
    Witte T, Wordelmann K, Schmidt RE.
    Immunology; 1990 Jan 15; 69(1):166-70. PubMed ID: 2179129
    [Abstract] [Full Text] [Related]

  • 37. [Chronic fatigue syndrome--study of 51 cases treated at the Second Tokyo National Hospital].
    Nishikai M.
    Nihon Rinsho; 1992 Nov 15; 50(11):2641-7. PubMed ID: 1337560
    [Abstract] [Full Text] [Related]

  • 38. [Chronic fatigue syndrome associated with Epstein-Barr virus infection].
    Parras F, Salvá F, Reina J, Gil J, Portela D, Alomar P.
    Med Clin (Barc); 1989 Apr 29; 92(16):619-22. PubMed ID: 2545980
    [Abstract] [Full Text] [Related]

  • 39. [Severe chronic Epstein-Barr virus infection with natural killer cell defect].
    Hartung K, Le Blanc S, Franz A, Jacobs R, Wittekind C, Bornkamm GW, Schmidt RE.
    Dtsch Med Wochenschr; 1988 Dec 16; 113(50):1960-3. PubMed ID: 2848676
    [Abstract] [Full Text] [Related]

  • 40. [Chronic fatigue immune dysfunction syndrome].
    Uchida A.
    Nihon Rinsho; 1992 Nov 16; 50(11):2625-9. PubMed ID: 1287238
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.